9 METERS BIOPHARMA, INC. Annual Operating Income (Loss) in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
9 Meters Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2022.
  • 9 Meters Biopharma, Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$12.8M, a 12.5% decline year-over-year.
  • 9 Meters Biopharma, Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$43.4M, a 1.67% decline year-over-year.
  • 9 Meters Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$42M, a 14.3% decline from 2021.
  • 9 Meters Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$36.8M, a 39.6% increase from 2020.
  • 9 Meters Biopharma, Inc. annual Operating Income (Loss) for 2020 was -$60.9M, a 138% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$42M -$5.26M -14.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 -$36.8M +$24.1M +39.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$60.9M -$35.3M -138% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 -$25.5M -$43.8M -240% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 $18.2M +$7.05M +63.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $11.2M +$17.1M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$5.94M +$517K +8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-14
2015 -$6.46M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.